+1 862-686-2696
Featured Products
Primary Cells
Immortalized Cell Lines
Stem Cells
Tumor Cell Lines
Transfected Stable Cell Lines
Exosomes
MicroRNA Agomir/Antagomir
Cell Culture Media, Kits & Reagents
Explore Products
Cell
Cell
MicroRNA
MicroRNA
Test and Analysis
Test and Analysis
Primary Cells

Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated)

  • For research use only

Cat No.

ABC-TC3008
Product Type

Immune Cells
Cell Type

B Cell
Species

Human
Growth Conditions

37 ℃, 5% CO2
Source Organ

Peripheral Blood
Disease

Acute Lymphoid Leukemia
Storage

Liquid Nitrogen

Acute Lymphoid Leukemia PB CD19+ B Cells support leukemia research, B-cell immunology, and targeted therapy evaluation in hematologic cancer studies.

Product Image
  • Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated)
Get a Quote
Home | Primary Cells | Human Primary Cells | Immune System Primary Cells | Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated)

Description

Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated) are isolated from the peripheral blood (PB) of human patients with newly diagnosed, untreated acute lymphoid leukemia (ALL), belonging to CD19+ B lymphocytes-round in morphology with suspension growth. As non-passageable primary cells, they retain native pathological phenotypes of de novo ALL, mediating immune-related functions and serving as a physiologically relevant model for studying ALL pathogenesis, drug sensitivity, and immune-based therapies. The cells highly express CD19 antigen. To ensure the quality of these primary cells, repeated freeze-thaw cycles are not recommended due to the fragile nature of these cells. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated), ALL PB CD19+ B cells ND/UT, ALL PB CD19+ B cells
Species

Human
Cat.No

ABC-TC3008
Product Category

Primary Cells
Size/Quantity

1 vial
Cell Type

B Cell
Growth Mode

Suspension
Shipping Info

Dry Ice
Growth Conditions

37 ℃, 5% CO2
Source Organ

Peripheral Blood
Disease

Acute Lymphoid Leukemia
Biosafety Level

1
Storage

Liquid Nitrogen
Product Type

Immune Cells
Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • These CD19+ B cells are well-suited for immunophenotyping, flow cytometry, single-cell RNA-seq, and functional assays of B cell receptor signaling. They are ideal for studying ALL pathogenesis, resistance mechanisms to targeted therapies like blinatumomab or CAR-T, and serve as a platform for drug screening, apoptosis assays, and biomarker validation. Researchers can use them to model disease heterogeneity or assess immune cell interactions in leukemia progression.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

  • Online Inquiry
  • Product Reviews

Inquiring Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

Let's Advance Life Science Research Together

Contact Us
AcceGen Scroll Top Button